A non-inferiority, phase III trial of gemcitabine plus capecitabine <i>versus</i> gemcitabine plus carboplatin as first-line therapy and tumor-infiltrating lymphocytes as a prognostic biomarker in patients with advanced triple-negative breast cancerXiaodong Liu, Zhongsheng Tong, Weipeng Zhao et al.|Therapeutic Advances in Medical Oncology|2024Cited by 2
Abstract P3-08-61: The association of disease free survival and the impact of tumor subtype on overall survival in advanced breast cancer patients: A real-world study from the China National Cancer CenterYiqun Li, Zijing Wang, Binghe Xu et al.|Cancer Research|2020Cited by 0
Abstract PS7-87: Incidence, treatment and survival of patients with brain metastases at initial metastatic breast cancer diagnosis: A real-world experience in national cancer center, ChinaYiqun Li, Binghe Xu, Yimeng Chen et al.|Cancer Research|2021Cited by 0